Nonagon Enables Clinical-Grade Remote Examinations for Heart, Lungs, Abdomen, and More, Potentially Improving Health Outcomes and Reducing Hospital Visits
Nonagon has received FDA clearance to sell its N9+ device as an over-the-counter product, making remote patient examinations more accessible than ever. The Nonagon N9+ device allows for clinical-grade remote examinations of various health parameters, including the heart, lungs, abdomen, oxygen saturation, ears, mouth/throat, skin, and body temperature, and automatically documents and shares exam results with physicians via telehealth, potentially contributing to better patient care and outcomes.
“We are thrilled to receive FDA clearance for the Nonagon N9+ device, which brings us one step closer to our mission of making remote digital medicine clinically reliable and accessible to the community,” said Alon Natanson, CEO of Nonagon. “This clearance allows us to offer a cutting-edge solution that empowers patients to proactively manage their health and enhances the capabilities of healthcare providers to remotely monitor and diagnose patients.”